Production (Stage)
Iovance Biotherapeutics, Inc.
IOVA
$2.21
$0.167.81%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.99% | 15.69% | 9.99% | 64.43% | -43.13% |
| Total Receivables | 30,215.38% | 45,820.53% | -- | 95,669.70% | -- |
| Inventory | 272.06% | 396.72% | 319.55% | 186.56% | -- |
| Prepaid Expenses | 38.37% | -29.10% | -43.88% | -28.44% | -0.02% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 32.97% | 48.46% | 30.32% | 75.44% | -39.55% |
|
|
|||||
| Total Current Assets | 32.97% | 48.46% | 30.32% | 75.44% | -39.55% |
| Net Property, Plant & Equipment | -11.36% | -6.95% | -0.08% | -0.05% | 1.64% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -3.04% | 23.18% | 37.13% | 25.39% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -6.59% | -89.91% | -90.05% | -89.98% | 0.86% |
| Total Assets | 11.14% | 16.67% | 16.29% | 27.34% | 5.46% |
|
|
|||||
| Total Accounts Payable | 10.85% | -16.95% | 64.40% | -34.47% | -18.60% |
| Total Accrued Expenses | 73.06% | 12.27% | 29.25% | 43.66% | 22.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -14.25% | 65.82% | 10.35% | 5.25% | -12.18% |
| Total Finance Division Other Current Liabilities | 334.56% | 176.90% | -58.18% | -64.71% | -75.03% |
| Total Other Current Liabilities | 334.56% | 176.90% | -58.18% | -64.71% | -75.03% |
| Total Current Liabilities | 47.44% | 10.91% | 29.80% | 5.64% | -4.65% |
|
|
|||||
| Total Current Liabilities | 47.44% | 10.91% | 29.80% | 5.64% | -4.65% |
| Long-Term Debt | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -38.83% | -33.87% | -2.38% | 0.58% | 3.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -4.02% | 86.29% | 75.63% | 57.62% | -- |
| Total Liabilities | 4.78% | 2.19% | 22.07% | 9.54% | 20.22% |
|
|
|||||
| Common Stock & APIC | 16.29% | 19.33% | 18.77% | 26.69% | 19.74% |
| Retained Earnings | -17.66% | -18.49% | -21.62% | -24.70% | -26.83% |
| Treasury Stock & Other | 5,325.86% | -141.41% | 278.54% | 61.85% | 192.06% |
| Total Common Equity | 12.92% | 21.52% | 14.75% | 32.83% | 1.97% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -33.33% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -33.33% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 12.92% | 21.52% | 14.75% | 32.83% | 1.97% |
| Total Preferred Equity | -33.33% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.92% | 21.52% | 14.75% | 32.83% | 1.97% |
|
|
|||||